Biotech startups that raised Series C
Updated 23 Oct 2026
700
Companies
$29.4B
Last round total
100
Rows shown
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Microbiotica | Series C | $40.4M | 2026-10-16 | Cambridge | Biotech |
| 2 | OMass Therapeutics | Series C | $310.0M | 2026-10-15 | Oxford | Biotech |
| 3 | BigHat Biosciences | Series C | $75.0M | 2026-09-24 | San Mateo | Artificial intelligence |
| 4 | Basecamp Research | Series C | $140.0M | 2026-09-23 | London | Artificial intelligence |
| 5 | Sling Therapeutics | Series C | $123.0M | 2026-09-16 | Ann Arbor | Biotech |
| 6 | Yudao Bio | Series C | $40.0M | 2026-09-15 | Shanghai | Biotech |
| 7 | QL Biopharma | Series C | $44.7M | 2026-09-14 | Beijing | Biotech |
| 8 | ImmunoPhotonics | Series C | $10.1M | 2026-09-01 | St Louis | Biotech |
| 9 | AusperBio | Series C | $120.0M | 2026-08-27 | Hangzhou | Biotech |
| 10 | Realmind Biotech | Series C | $7.4M | 2026-08-20 | Shenzhen | Biotech |
| 11 | Bridge to Life | Series C | $110.0M | 2026-08-12 | Northbrook | Biotech |
| 12 | Epicrispr Biotechnologies | Series C | $90.0M | 2026-08-11 | South San Francisco | Biotech |
| 13 | Hopstem | Series C | $29.6M | 2026-08-10 | Hangzhou | Biotech |
| 14 | Ratio Therapeutics | Series C | $70.0M | 2026-07-31 | Boston | Biotech |
| 15 | CoreMap | Series C | $37.0M | 2026-07-29 | Burlington | Biotech |
| 16 | Diyingjia Technology | Series C | $3.0M | 2026-07-28 | Beijing | Artificial intelligence |
| 17 | SIYO Bio-Tech | Series C | $31.7M | 2026-07-26 | Beijing | Biotech |
| 18 | Shengqiang Technology | Series C | $13.7M | 2026-07-26 | Shenzhen | Biotech |
| 19 | Delova Biotech | Series C | $88.6M | 2026-07-22 | Qixia | Biotech |
| 20 | Trellis Bioscience | Series C | $9.0M | 2026-07-16 | San Francisco | Biotech |
| 21 | Chai Discovery | Series C | $400.0M | 2026-07-14 | San Francisco | Artificial intelligence |
| 22 | NNB Nutrition | Series C | $29.5M | 2026-07-13 | Nanjing | Biotech |
| 23 | Allotera Therapeutics | Series C | $35.0M | 2026-07-08 | St Louis | Biotech |
| 24 | Cyllene Therapeutics | Series C | $37.7M | 2026-07-07 | Paris | Biotech |
| 25 | Huaxia Yingtai | Series C | $29.4M | 2026-07-06 | Changping | Biotech |
| 26 | iRegene | Series C | $38.3M | 2026-07-02 | Wuhan | Biotech |
| 27 | Flare Therapeutics | Series C | $85.0M | 2026-06-30 | Cambridge | Biotech |
| 28 | Automata | Series C | $45.0M | 2026-06-25 | London | Artificial intelligence |
| 29 | Cellanome | Series C | $75.9M | 2026-06-18 | Redwood City | Biotech |
| 30 | Triveni Bio | Series C | $65.0M | 2026-06-17 | Watertown | Biotech |
| 31 | Junhemeng Biopharmaceutical | Series C | $29.5M | 2026-06-08 | Hangzhou | Biotech |
| 32 | CereVasc | Series C | $85.0M | 2026-06-04 | Charlestown | Biotech |
| 33 | Weikaier Pharmaceutical Technology | Series C | $29.6M | 2026-06-02 | Nanjing | Biotech |
| 34 | Tongee Medical Technology | Series C | $14.8M | 2026-06-01 | Hangzhou | Biotech |
| 35 | YolTech Therapeutics | Series C | $73.8M | 2026-05-29 | Minhang | Biotech |
| 36 | Prellis Biologics | Series C | 2026-05-27 | Berkeley | Biotech | |
| 37 | Toregem BioPharma | Series C | $5.3M | 2026-05-19 | Kawaramachi | Biotech |
| 38 | Accro Bioscience | Series C | $50.0M | 2026-05-18 | Suzhou | Biotech |
| 39 | Cerevance | Series C | $20.0M | 2026-05-12 | Boston | Biotech |
| 40 | Storm Therapeutics | Series C | $56.0M | 2026-04-16 | Cambridge | Biotech |
| 41 | Terremoto Biosciences | Series C | $108.0M | 2026-04-15 | San Francisco | Biotech |
| 42 | ADCendo | Series C | $75.0M | 2026-04-14 | Copenhagen | Biotech |
| 43 | Conmind Medical | Series C | $29.1M | 2026-04-07 | Shenzhen | Biotech |
| 44 | XellSmart | Series C | $72.6M | 2026-04-01 | Minhang | Biotech |
| 45 | Terrestrial Bio | Series C | $50.0M | 2026-03-26 | Cambridge | Biotech |
| 46 | CellGenes Biotechnology | Series C | $14.5M | 2026-03-24 | Guangzhou | Biotech |
| 47 | Connext | Series C | $10.0M | 2026-03-16 | Daegu | Biotech |
| 48 | Mustbio | Series C | $23.3M | 2026-03-13 | Seoul | Biotech |
| 49 | Tropic Biosciences | Series C | $105.0M | 2026-03-12 | London | Biotech |
| 50 | Cognito Therapeutics | Series C | $105.0M | 2026-03-05 | Cambridge | Biotech |
| 51 | ANEUVO | Series C | $22.0M | 2026-03-05 | Los Angeles | Biotech |
| 52 | Brainomix | Series C | $6.5M | 2026-02-24 | Oxford | Artificial intelligence |
| 53 | Loyal | Series C | $100.0M | 2026-02-11 | San Francisco | Biotech |
| 54 | Regend Therapeutics | Series C | $50.6M | 2026-02-11 | Suzhou | Biotech |
| 55 | Huaguan Biotechnology | Series C | $14.4M | 2026-02-04 | Beijing | Biotech |
| 56 | Colossal Biosciences | Series C | $60.0M | 2026-02-03 | Austin | Biotech |
| 57 | Nuclera | Series C | $12.0M | 2026-01-13 | Cambridge | Biotech |
| 58 | Zenitar | Series C | $86.0M | 2026-01-12 | Chengdu | Biotech |
| 59 | bit.bio | Series C | $50.0M | 2026-01-09 | Cambridge | Biotech |
| 60 | Beacon Therapeutics | Series C | $75.0M | 2026-01-08 | Alachua | Biotech |
| 61 | Ukko | Series C | $45.0M | 2026-01-08 | Palo Alto | Biotech |
| 62 | Soley Therapeutics | Series C | $200.0M | 2026-01-07 | San Francisco | Biotech |
| 63 | Refine Biology | Series C | $14.3M | 2025-12-29 | Beijing | Biotech |
| 64 | Sumgen Biotech | Series C | 2025-12-29 | Hangzhou | Biotech | |
| 65 | DP Technology | Series C | $113.9M | 2025-12-24 | Haidian | Artificial intelligence |
| 66 | Culture Biosciences | Series C | $80.0M | 2025-12-16 | San Francisco | Biotech |
| 67 | Darwin Cell Biology | Series C | $27.9M | 2025-12-08 | Beijing | Biotech |
| 68 | Aspen Neuroscience | Series C | $115.0M | 2025-11-20 | San Diego | Biotech |
| 69 | Healsun Biopharm | Series C | $27.8M | 2025-11-19 | Hangzhou | Biotech |
| 70 | 4TEEN4 Pharmaceuticals | Series C | $36.1M | 2025-11-13 | Hennigsdorf | Biotech |
| 71 | Kind Pharmaceutical | Series C | $56.2M | 2025-11-12 | Hangzhou | Biotech |
| 72 | Newracle Genetics | Series C | $7.6M | 2025-11-03 | Seoul | Biotech |
| 73 | Venture Med Group | Series C | $28.0M | 2025-10-29 | Plymouth | Biotech |
| 74 | Hemab | Series C | $157.0M | 2025-10-27 | Copenhagen | Biotech |
| 75 | Electra Therapeutics | Series C | $183.0M | 2025-10-22 | San Francisco | Biotech |
| 76 | MarvelBiome | Series C | $39.6M | 2025-10-22 | Woburn | Biotech |
| 77 | Instylla | Series C | $21.7M | 2025-10-17 | Waltham | Biotech |
| 78 | Animol Discovery | Series C | $12.0M | 2025-10-17 | Boston | Biotech |
| 79 | Tubulis | Series C | $400.6M | 2025-10-15 | Munich | Biotech |
| 80 | GRIT Biotechnology | Series C | $84.0M | 2025-10-14 | Shanghai | Biotech |
| 81 | IMBiologics | Series C | $29.5M | 2025-10-14 | Suwon | Biotech |
| 82 | Lumen Bioscience | Series C | $30.0M | 2025-10-08 | Seattle | Biotech |
| 83 | TORL BioTherapeutics | Series C | $96.0M | 2025-10-07 | Culver City | Biotech |
| 84 | Affinia Therapeutics | Series C | $40.0M | 2025-10-07 | Waltham | Biotech |
| 85 | SelectION | Series C | $5.4M | 2025-09-15 | San Diego | Biotech |
| 86 | Cutiss | Series C | $38.8M | 2025-09-10 | Zürich | Biotech |
| 87 | Plexium | Series C | $60.1M | 2025-08-25 | San Diego | Biotech |
| 88 | InxMed | Series C | $34.0M | 2025-08-22 | Shanghai | Biotech |
| 89 | Kromatid | Series C | $8.0M | 2025-08-20 | Longmont | Biotech |
| 90 | Gameto | Series C | $44.0M | 2025-08-12 | New York | Biotech |
| 91 | Haichang Biotech | Series C | $69.6M | 2025-08-08 | Hangzhou | Biotech |
| 92 | Luxna Biotech | Series C | $1.0M | 2025-08-07 | Osaka | Biotech |
| 93 | Mirvie | Series C | $23.7M | 2025-08-01 | South San Francisco | Biotech |
| 94 | Yantai Lannacheng Biotechnology | Series C | $41.8M | 2025-07-20 | Yantai | Biotech |
| 95 | Guangzhou Xinji Pharmaceutical | Series C | 2025-07-14 | Guangzhou | Biotech | |
| 96 | Shuwen Biotech | Series C | $13.9M | 2025-07-09 | Deqing | Biotech |
| 97 | GeneCentric Therapeutics | Series C | $8.0M | 2025-06-18 | Durham | Biotech |
| 98 | Arima Genomics | Series C | $22.0M | 2025-06-17 | San Diego | Biotech |
| 99 | ENYO Pharma | Series C | $7.0M | 2025-06-12 | Lyon | Biotech |
| 100 | QureBio | Series C | $13.9M | 2025-06-05 | Shanghai | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 700.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Tubulis | Series C | $400.6M | 2025-10-15 | Munich | Biotech |
| 2 | Chai Discovery | Series C | $400.0M | 2026-07-14 | San Francisco | Artificial intelligence |
| 3 | Insitro | Series C | $400.0M | 2021-03-15 | South San Francisco | Artificial intelligence |
| 4 | ArsenalBio | Series C | $325.0M | 2024-09-04 | South San Francisco | Biotech |
| 5 | OMass Therapeutics | Series C | $310.0M | 2026-10-15 | Oxford | Biotech |
| 6 | ACELYRIN | Series C | $300.0M | 2022-09-13 | Los Angeles | Biotech |
| 7 | MegaRobo | Series C | $300.0M | 2022-06-15 | Beijing | Artificial intelligence |
| 8 | Abogen Biosciences | Series C | $300.0M | 2021-11-29 | Suzhou | Biotech |
| 9 | Heyuan Biotechnology | Series C | $300.0M | 2020-06-01 | Shanghai | Biotech |
| 10 | Insilico | Series C | $290.7M | 2021-06-24 | Gunpo | Biotech |
| 11 | ProBio Inc. | Series C | $220.0M | 2023-01-18 | Pennington | Biotech |
| 12 | Tempo | Series C | $220.0M | 2021-04-13 | San Francisco | Biotech |
| 13 | Mojave Pharma | Series C | $220.0M | 2017-10-01 | Las Vegas | Biotech |
| 14 | Aviceda Therapeutics | Series C | $207.5M | 2025-01-07 | Cambridge | Biotech |
| 15 | InterVenn | Series C | $201.0M | 2021-08-02 | South San Francisco | Artificial intelligence |
| 16 | Soley Therapeutics | Series C | $200.0M | 2026-01-07 | San Francisco | Biotech |
| 17 | NiKang Therapeutics | Series C | $200.0M | 2021-05-26 | Wilmington | Biotech |
| 18 | Genuity Science | Series C | $200.0M | 2018-11-27 | Boston | Artificial intelligence |
| 19 | Electra Therapeutics | Series C | $183.0M | 2025-10-22 | San Francisco | Biotech |
| 20 | Bluejay Therapeutics | Series C | $182.0M | 2024-05-09 | San Mateo | Biotech |
| 21 | Sionna Therapeutics | Series C | $182.0M | 2024-03-06 | Natick | Biotech |
| 22 | Deep Genomics | Series C | $180.0M | 2021-07-28 | Toronto | Artificial intelligence |
| 23 | Alpha-9 Oncology | Series C | $175.0M | 2024-10-23 | Vancouver | Biotech |
| 24 | Nutcracker Therapeutics | Series C | $167.0M | 2022-03-14 | Emeryville | Biotech |
| 25 | Mabworks | Series C | $160.0M | 2020-04-16 | Beijing | Biotech |
| 26 | Hemab | Series C | $157.0M | 2025-10-27 | Copenhagen | Biotech |
| 27 | RecBio | Series C | $156.3M | 2021-06-14 | Taizhou | Biotech |
| 28 | Brii Biosciences | Series C | $155.0M | 2021-03-23 | Beijing | Biotech |
| 29 | Hangzhou DAC Biotech Co., Ltd | Series C | $154.9M | 2021-05-12 | Hangzhou | Biotech |
| 30 | Atsena Therapeutics | Series C | $150.0M | 2025-04-02 | Durham | Biotech |
| 31 | Scorpion Therapeutics | Series C | $150.0M | 2024-07-16 | Boston | Biotech |
| 32 | ConcertAI | Series C | $150.0M | 2022-03-29 | Cambridge | Artificial intelligence |
| 33 | Element Science | Series C | $145.6M | 2020-03-03 | San Francisco | Biotech |
| 34 | GI Innovation | Series C | $143.2M | 2021-06-15 | Seoul | Biotech |
| 35 | Basecamp Research | Series C | $140.0M | 2026-09-23 | London | Artificial intelligence |
| 36 | Amolyt Pharma | Series C | $138.6M | 2023-01-06 | Écully | Biotech |
| 37 | Vividion Therapeutics | Series C | $135.0M | 2021-02-24 | San Diego | Biotech |
| 38 | Endeavor BioMedicines | Series C | $132.5M | 2024-04-24 | Solana Beach | Biotech |
| 39 | Cloudbreak Therapeutics | Series C | $130.0M | 2022-01-01 | Irvine | Biotech |
| 40 | Modern Meadow | Series C | $130.0M | 2021-04-29 | Pine Brook | Biotech |
| 41 | Bohai New Enzyme | Series C | $125.0M | 2021-11-05 | Shanghai | Biotech |
| 42 | Hummingbird Bioscience | Series C | $125.0M | 2021-05-18 | Woodlands | Biotech |
| 43 | OneSource | Series C | $125.0M | 2021-03-19 | bangalore-karnataka | Biotech |
| 44 | Paige | Series C | $125.0M | 2021-01-14 | New York | Artificial intelligence |
| 45 | Sling Therapeutics | Series C | $123.0M | 2026-09-16 | Ann Arbor | Biotech |
| 46 | Senda Biosciences | Series C | $123.0M | 2022-08-16 | Cambridge | Biotech |
| 47 | Cellarity | Series C | $121.0M | 2022-10-04 | Somerville | Biotech |
| 48 | AusperBio | Series C | $120.0M | 2026-08-27 | Hangzhou | Biotech |
| 49 | Escient Pharmaceuticals | Series C | $120.0M | 2022-11-28 | San Diego | Biotech |
| 50 | Evolved By Nature | Series C | $120.0M | 2022-06-30 | Medford | Biotech |
| 51 | Belief BioMed | Series C | $120.0M | 2022-04-01 | Minhang | Biotech |
| 52 | EpimAb Biotherapeutics | Series C | $120.0M | 2021-03-22 | Shanghai | Biotech |
| 53 | Aspen Neuroscience | Series C | $115.0M | 2025-11-20 | San Diego | Biotech |
| 54 | Glycomine | Series C | $115.0M | 2025-04-16 | San Carlos | Biotech |
| 55 | Nusano | Series C | $115.0M | 2024-10-01 | Valencia | Biotech |
| 56 | DP Technology | Series C | $113.9M | 2025-12-24 | Haidian | Artificial intelligence |
| 57 | Elektrofi | Series C | $112.2M | 2024-08-22 | Boston | Biotech |
| 58 | Bridge to Life | Series C | $110.0M | 2026-08-12 | Northbrook | Biotech |
| 59 | Eyetech Pharmaceuticals | Series C | $108.5M | 2001-08-08 | New York | Biotech |
| 60 | Terremoto Biosciences | Series C | $108.0M | 2026-04-15 | San Francisco | Biotech |
| 61 | Jun Shengtai | Series C | $107.0M | 2023-01-05 | Shenzhen | Biotech |
| 62 | Jnana Therapeutics | Series C | $107.0M | 2022-11-15 | Boston | Biotech |
| 63 | Annoroad | Series C | $105.5M | 2017-11-03 | Beijing | Biotech |
| 64 | Tropic Biosciences | Series C | $105.0M | 2026-03-12 | London | Biotech |
| 65 | Cognito Therapeutics | Series C | $105.0M | 2026-03-05 | Cambridge | Biotech |
| 66 | Geneoscopy | Series C | $105.0M | 2025-01-08 | Saint Louis | Biotech |
| 67 | Elpiscience Biopharmaceuticals | Series C | $105.0M | 2021-05-13 | Shanghai | Biotech |
| 68 | Arch Oncology | Series C | $105.0M | 2021-04-27 | St Louis | Biotech |
| 69 | Personal Genome Diagnostics | Series C | $103.0M | 2021-02-10 | Baltimore | Biotech |
| 70 | Loyal | Series C | $100.0M | 2026-02-11 | San Francisco | Biotech |
| 71 | Biolinq | Series C | $100.0M | 2025-03-19 | San Diego | Biotech |
| 72 | Umoja Biopharma | Series C | $100.0M | 2025-01-14 | Seattle | Biotech |
| 73 | SiteOne Therapeutics | Series C | $100.0M | 2024-12-18 | South San Francisco | Biotech |
| 74 | Autobahn Therapeutics | Series C | $100.0M | 2024-07-24 | San Diego | Biotech |
| 75 | Asceneuron | Series C | $100.0M | 2024-07-16 | Lausanne | Biotech |
| 76 | Karius | Series C | $100.0M | 2024-05-02 | Redwood City | Artificial intelligence |
| 77 | MitrAssist | Series C | $100.0M | 2023-09-26 | Misgav Dov | Biotech |
| 78 | Boundless Bio | Series C | $100.0M | 2023-05-16 | La Jolla | Biotech |
| 79 | Synthekine | Series C | $100.0M | 2023-01-06 | Menlo Park | Biotech |
| 80 | HotSpot Therapeutics | Series C | $100.0M | 2021-11-29 | Boston | Biotech |
| 81 | Leads Biolabs | Series C | $100.0M | 2021-10-08 | Nanjing | Biotech |
| 82 | Kalypsys | Series C | $100.0M | 2006-11-29 | San Diego | Biotech |
| 83 | Archimedes Pharma | Series C | $99.0M | 2010-04-05 | Reading | Biotech |
| 84 | V-Wave | Series C | $98.0M | 2021-12-16 | Caesarea | Biotech |
| 85 | Kinnate Biopharma | Series C | $98.0M | 2020-08-26 | San Diego | Biotech |
| 86 | Antengene Corporation | Series C | $97.0M | 2020-07-20 | Shanghai | Biotech |
| 87 | Evox Therapeutics | Series C | $96.7M | 2021-02-18 | Oxford | Biotech |
| 88 | TORL BioTherapeutics | Series C | $96.0M | 2025-10-07 | Culver City | Biotech |
| 89 | ByHeart | Series C | $95.0M | 2024-05-13 | New York | Biotech |
| 90 | Ajax Therapeutics | Series C | $95.0M | 2024-05-13 | Cambridge | Biotech |
| 91 | Teligene | Series C | $92.9M | 2021-02-24 | Nanjing | Biotech |
| 92 | Ab&B Biotech | Series C | $92.7M | 2021-07-16 | Taizhou | Biotech |
| 93 | Be Biopharma | Series C | $92.0M | 2025-01-15 | Cambridge | Biotech |
| 94 | Epicrispr Biotechnologies | Series C | $90.0M | 2026-08-11 | South San Francisco | Biotech |
| 95 | Attovia Therapeutics | Series C | $90.0M | 2025-04-15 | San Carlos | Biotech |
| 96 | Bright Peak Therapeutics | Series C | $90.0M | 2024-06-11 | Allschwil | Biotech |
| 97 | Forge Biologics | Series C | $90.0M | 2022-09-12 | Grove City | Biotech |
| 98 | Strata Oncology | Series C | $90.0M | 2021-07-28 | Ann Arbor | Biotech |
| 99 | Delova Biotech | Series C | $88.6M | 2026-07-22 | Qixia | Biotech |
| 100 | Ring Therapeutics | Series C | $86.5M | 2023-03-09 | Cambridge | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 700.
By month
| Month | Companies |
|---|---|
| 2024-11 | 6 |
| 2024-12 | 8 |
| 2025-01 | 7 |
| 2025-02 | 2 |
| 2025-03 | 3 |
| 2025-04 | 7 |
| 2025-05 | 4 |
| 2025-06 | 7 |
| 2025-07 | 3 |
| 2025-08 | 7 |
| 2025-09 | 2 |
| 2025-10 | 12 |
| 2025-11 | 5 |
| 2025-12 | 5 |
| 2026-01 | 6 |
| 2026-02 | 5 |
| 2026-03 | 7 |
| 2026-04 | 5 |
| 2026-05 | 5 |
| 2026-06 | 8 |
| 2026-07 | 13 |
| 2026-08 | 5 |
| 2026-09 | 6 |
| 2026-10 | 2 |
Table 3. Biotech startups that raised Series C by month of the round. Source: FundingWatcher. Data as of 23 October 2026. Base: 700.
Country
| Country | Companies |
|---|---|
| United States | 338 |
| China | 160 |
| United Kingdom | 39 |
| South Korea | 33 |
| Switzerland | 20 |
| Japan | 15 |
| Germany | 15 |
| Israel | 15 |
| Canada | 12 |
| France | 11 |
| Denmark | 5 |
| The Netherlands | 5 |
| Spain | 4 |
| Belgium | 4 |
| Ireland | 3 |
Table 4. Biotech startups that raised Series C by country. Source: FundingWatcher. Data as of 23 October 2026. Base: 700.
City
| City | Companies |
|---|---|
| Shanghai | 29 |
| San Francisco | 26 |
| San Diego | 26 |
| Cambridge | 22 |
| Hangzhou | 20 |
| Beijing | 19 |
| Nanjing | 15 |
| Boston | 13 |
| Seoul | 13 |
| Guangzhou | 12 |
| Menlo Park | 12 |
| London | 10 |
| Shenzhen | 10 |
| Suzhou | 10 |
| Cambridge | 9 |
Table 5. Biotech startups that raised Series C by city. Source: FundingWatcher. Data as of 23 October 2026. Base: 700.
Sector
| Sector | Companies |
|---|---|
| Biotech | 700 |
| Health care | 621 |
| Software | 66 |
| Artificial intelligence | 35 |
| Hardware | 27 |
| Fintech | 7 |
| Energy | 6 |
| Education | 2 |
| Cybersecurity | 1 |
Table 6. Biotech startups that raised Series C by sector. Source: FundingWatcher. Data as of 23 October 2026. Base: 700.
Biotech at other stages
Other sectors that raised Series C
software startups that raised Series C2,403
health care startups that raised Series C1,245
AI startups that raised Series C626
fintech startups that raised Series C627
commerce startups that raised Series C639
hardware startups that raised Series C1,108
education startups that raised Series C185
cybersecurity startups that raised Series C296
energy startups that raised Series C193
Cite: FundingWatcher, 700 biotech companies whose most recent round is Series C, 23 October 2026. https://fundingwatcher.com/startups/biotech/series-c/